Download PDF
Exp Clin Endocrinol Diabetes 2017; 125(01): 57-63
DOI: 10.1055/s-0042-109866
Article
© Georg Thieme Verlag KG Stuttgart · New York

Markers of Subclinical Cardiovascular Disease in Nonfunctional Adrenal Incidentaloma Patients without Traditional Cardiovascular Risk Factors

Güven Barış Cansu
1   Division of Endocrinology and Metabolism, Yunusemre State Hospital, Eskişehir, Turkey
,
Ramazan Sarı
2   Division of Endocrinology and Metabolism, School of Medicine, Akdeniz University, Antalya, Turkey
,
Nusret Yılmaz
3   Division of Endocrinology and Metabolism, Şırnak State Hospital, Şırnak, Turkey
,
Sebahat Özdem
4   Biochemistry, School of Medicine, Akdeniz University, Antalya, Turkey
,
Metin Çubuk
5   Radiology, School of Medicine, Akdeniz University, Antalya, Turkey
› Author Affiliations
Further Information

Publication History

received 18 August 2015
first decision 17 May 2016

accepted 06 June 2016

Publication Date:
29 September 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Introduction: Data regarding cardiovascular risk in patients with non-functional adrenal incidentaloma (NFAI) are limited. The objectives of this study are to investigate markers of subclinical cardiovascular disease like carotid intima media thickness (CIMT), pulse wave velocity (PWV), augmentation index (AIx), soluble CD40 ligand (sCD40L) and leptin levels in NFAI patients without traditional cardiovascular risk factors and healthy control group.

Methods: This study involved 35 patients with NFAI (11 males, 24 females; mean age, 52.4±7.7 years) and 35 healthy subjects as control group (11 males, 24 females; mean age, 51.8±7.2 years). CIMT was evaluated by ultrasonographical methods. PWV and AIx were measured with TensioClinic arteriograph system. Serum leptin and sCD40L levels were measured by ELISA.

Results: In NFAI patients group; CIMT (p<0.001), PWV (p<0.001), AIx brachial (p<0.001) and AIx aorta (p=0.008) were found higher than the control group. Cortisol levels after 1mg dexamethasone suppression test (DST) were higher (p=0.006) and DHEASO4 levels were lower (p=0.008) in NFAI patients than control group. We found that CIMT had positive correlation with age (r=0.484, p<0.005), triglycerides (r=0.378, p<0.005) and cortisol level after 1 mg DST (r=0.346, p<0.005); PWV had positive correlation with total cholesterol (r=0.338, p<0.005) triglycerides (r=0.335, p<0.05) and insulin levels (r=0.426, p<0.005); AIx brachial had a positive correlation with triglycerides (r=0414, p<0.05) and negative correlation with DHEASO4 (r=−0.380, p<0.005); leptin levels had a positive correlation with body mass index (r=0.541, p<0.001) and HOMA-IR index.

Conclusion: We showed that subjects with NFAI without traditional cardiovascular risk factors featured several disturbances (CIMT, PWV and AIx) compared to the control group that could be attributable to increased cardiovascular risk.

Key words

non-functional adrenal incidentaloma - carotid intima media thickness - pulse wave velocity - soluble CD40 ligand - leptin
 

  • References

  • 1 Comlekci A, Yener S, Ertilav S et al. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010; 37: 40-46
    CrossrefPubMedGoogle Scholar
  • 2 Di Dalmazi G, Vicennati V, Rinaldi E et al. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. European journal of endocrinology/European Federation of Endocrine Societies 2012; 166: 669-677
    CrossrefPubMedGoogle Scholar
  • 3 Yilmaz H, Tutuncu NB, Sahin M. Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas. Journal of endocrinological investigation 2009; 32: 913-916
    CrossrefPubMedGoogle Scholar
  • 4 Sehestedt T, Jeppesen J, Hansen TW et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. European heart journal 2010; 31: 883-891
    CrossrefPubMedGoogle Scholar
  • 5 Sehestedt T, Jeppesen J, Hansen TW et al. Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. Journal of hypertension 2012; 30: 1928-1936
    CrossrefPubMedGoogle Scholar
  • 6 Volpe M, Battistoni A, Tocci G et al. Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers. Journal of hypertension 2012; 30: 1056-1064
    CrossrefPubMedGoogle Scholar
  • 7 Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood pressure 2014; 23: 3-16
    CrossrefPubMedGoogle Scholar
  • 8 Yener S, Genc S, Akinci B et al. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine 2009; 35: 365-370
    CrossrefPubMedGoogle Scholar
  • 9 Housa D, Housova J, Vernerova Z et al. Adipocytokines and cancer. Physiological research/Academia Scientiarum Bohemoslovaca 2006; 55: 233-244
    PubMedGoogle Scholar
  • 10 Wallace AM, McMahon AD, Packard CJ et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052-3056
    CrossrefPubMedGoogle Scholar
  • 11 Yener S, Baris M, Secil M et al. Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?. Journal of endocrinological investigation 2011; 34: 265-270
    CrossrefPubMedGoogle Scholar
  • 12 Yener S, Comlekci A, Yuksel F et al. Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas. European journal of internal medicine 2012; 23: 83-87
    CrossrefPubMedGoogle Scholar
  • 13 Ermetici F, Malavazos AE, Corbetta S et al. Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism: clinical and experimental 2007; 56: 686-692
    CrossrefPubMedGoogle Scholar
  • 14 Antoniades C, Bakogiannis C, Tousoulis D et al. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. Journal of the American College of Cardiology 2009; 54: 669-677
    CrossrefPubMedGoogle Scholar
  • 15 Lutgens E, Gorelik L, Daemen MJ et al. Requirement for CD154 in the progression of atherosclerosis. Nature medicine 1999; 5: 1313-1316
    CrossrefPubMedGoogle Scholar
  • 16 de Lemos JA, Zirlik A, Schonbeck U et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arteriosclerosis, thrombosis, and vascular biology 2005; 25: 2192-2196
    CrossrefPubMedGoogle Scholar
  • 17 Hassan GS, Merhi Y, Mourad W. CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology 2012; 217: 521-532
    CrossrefPubMedGoogle Scholar
  • 18 National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421
    PubMedGoogle Scholar
  • 19 Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
    Google Scholar
  • 20 Schreuder FH, Graf M, Hameleers JM et al. Measurement of common carotid artery intima-media thickness in clinical practice: comparison of B-mode and RF-based technique. Ultraschall Med 2009; 30: 459-465
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Bianchini E, Bozec E, Gemignani V et al. Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine 2010; 29: 1169-1175
    PubMedGoogle Scholar
  • 22 Willekes C, Hoeks AP, Bots ML et al. Evaluation of off-line automated intima-media thickness detection of the common carotid artery based on M-line signal processing. Ultrasound in medicine & biology 1999; 25: 57-64
    CrossrefPubMedGoogle Scholar
  • 23 Baulmann J, Schillings U, Rickert S et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. Journal of hypertension 2008; 26: 523-528
    CrossrefPubMedGoogle Scholar
  • 24 Terzolo M, Pia A, Ali A et al. Adrenal incidentaloma: a new cause of the metabolic syndrome?. The Journal of clinical endocrinology and metabolism 2002; 87: 998-1003
    CrossrefPubMedGoogle Scholar
  • 25 Zhang W, Tang ZY, Wang WQ et al. Metabolic syndrome in patients with adrenocortical adenoma. Zhonghua yi xue za zhi 2006; 86: 3397-3400
    PubMedGoogle Scholar
  • 26 Peppa M, Koliaki C, Nikolopoulos P et al. Skeletal muscle insulin resistance in endocrine disease. Journal of biomedicine & biotechnology 2010; 2010 527850
    PubMedGoogle Scholar
  • 27 Androulakis II, Kaltsas GA, Kollias GE et al. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. The Journal of clinical endocrinology and metabolism 2014; 99: 2754-2762
    CrossrefPubMedGoogle Scholar
  • 28 de Groot E, van Leuven SI, Duivenvoorden R et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nature clinical practice Cardiovascular medicine 2008; 5: 280-288
    CrossrefPubMedGoogle Scholar
  • 29 Juonala M, Kahonen M, Laitinen T et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. European heart journal 2008; 29: 1198-1206
    CrossrefPubMedGoogle Scholar
  • 30 Sandrock M, Hansel J, Schulze J et al. Sequentially based analysis versus image based analysis of Intima Media Thickness in common carotid arteries studies – do major IMT studies underestimate the true relations for cardio- and cerebrovascular risk?. Cardiovascular ultrasound 2008; 6: 32
    CrossrefPubMedGoogle Scholar
  • 31 Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. Journal of hypertension 2003; 21: 463-472
    CrossrefPubMedGoogle Scholar
  • 32 Weber T, Auer J, O’Rourke MF et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-189
    CrossrefPubMedGoogle Scholar
  • 33 Mattace-Raso FU, van der Cammen TJ, Hofman A et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663
    CrossrefPubMedGoogle Scholar
  • 34 Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Current opinion in cardiology 2002; 17: 543-551
    CrossrefPubMedGoogle Scholar
  • 35 McEniery CM, Yasmin Hall IR. et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). Journal of the American College of Cardiology 2005; 46: 1753-1760
    CrossrefPubMedGoogle Scholar
  • 36 Ashizawa N, Takagi M, Seto S et al. Serum adiponectin and leptin in a patient with Cushing’s syndrome before and after adrenalectomy. Intern Med 2007; 46: 383-385
    CrossrefPubMedGoogle Scholar
  • 37 Tuna MM, Imga NN, Dogan BA et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. Journal of endocrinological investigation 2014; 37: 765-768
    CrossrefPubMedGoogle Scholar
  • 38 Schonbeck U, Varo N, Libby P et al. Soluble CD40L and cardiovascular risk in women. Circulation 2001; 104: 2266-2268
    CrossrefPubMedGoogle Scholar
  • 39 Schonbeck U, Mach F, Libby P. CD154 (CD40 ligand). The international journal of biochemistry & cell biology 2000; 32: 687-693
    CrossrefPubMedGoogle Scholar
  • 40 Kristo C, Ueland T, Godang K et al. Biochemical markers for cardiovascular risk following treatment in endogenous Cushing’s syndrome. Journal of endocrinological investigation 2008; 31: 400-405
    CrossrefPubMedGoogle Scholar